Are You Developing Financial Projections?

Posted on
by Daniel M. Grauman,, Managing Director & CEO
and Jessica Stack, Senior Manager

Open PDF file >

Are you developing financial projections for business planning or an upcoming valuation?  During COVID-19, each organization was uniquely impacted by management decisions, state and local policy, and specialty-specific challenges or opportunities, etc. Normalizing financials moving forward should proceed with these considerations. Click here to view how various factors impact these projections.

Posted in Partnerships, M&A, and Finance

Anatomy of a Deal Series No. 1:
Anatomy of a Deal: Why 2021 Could Present Interesting Opportunities for Acquisitions

Posted on
by Daniel M. Grauman, Managing Director & CEO
Scott Stuecher, Manager

Open PDF file >

The road through COVID-19 likely will be uneven for not-for-profit systems, with factors such as geography, cash position, unemployment and soft demand for services all playing a role. But for some systems, year two of the pandemic could also prove to be the right time for growth. In our “Anatomy of a Deal” series, we’ll […]

Posted in Partnerships, M&A, and Finance

Choosing the Optimal Strategic Relationships

Posted on
by Mark Dubow, Director
and John Harris, Director

Open PDF file >

Your organization’s near-term success is dependent on emerging from COVID in full sprint to address critical strategic initiatives and new opportunities. Strategic relationships can provide access to capabilities, expertise and speed to market that are superior to a “build” or “buy” approach. While traditional relationships (other hospitals/systems, health plans, etc.) offer a degree of support, […]

Posted in Strategy & Planning

Making Sense of the Ever-Changing Medicare Physician Fee Schedule

Posted on
by Karin Chernoff Kaplan, Director,
and Richard Chasinoff, Principal
and Jack Lacy, Senior Associate

Open PDF file >

By now you’ve probably read (whether published by Veralon or another source) that there were significant changes made to the 2021 Medicare physician fee schedule (PFS). The entire program was originally intended to be budget neutral, but reimbursement was restructured to increase payments to cognitive specialties (such as primary care and other medical specialties) and […]

Posted in Provider Compensation

3 Questions Every System Should Answer Following the Medicare Hospital Outpatient Prospective and ASC Payment System Final Rule

Posted on
by Lynda Mischel, Principal
and Meredith Inniger, Manager

Open PDF file >

One of the most impactful final rules released by CMS in recent months is the CY 2021 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS-1736-FC). This rule includes several important policy changes, most notably the elimination of the Inpatient Only List on a phased schedule through CY2024 (when […]

Posted in Strategy & Planning

Radiation Oncology Alternative Payment Model: 3 Things to Do Now

Posted on
by Lynda Mischel, Principal
and Scott Stuecher, Manager

Open PDF file >

CMS is launching a Radiation Oncology Alternative Payment Model (“RO Model”) that will profoundly affect radiation oncology economics, with a target start date of January 1, 2022. The RO Model will apply (or at least test) a bundled payment methodology affecting about 30% of eligible radiation oncology episodes. Revenue reductions may be as high as […]

Posted in Strategy & Planning

Hospital M&A Series Part 6: Hospital M&A: Is This a Fair Deal? What to Consider

Posted on
by Daniel Grauman, Managing Director & CEO
and Kevin Cope, Manager

Open PDF file >

Board members of not-for-profit community hospitals face enormous pressure to protect their community’s access to care. Even when the economic reasons for hospital mergers and acquisitions (M&A) are compelling, the decision to give up control to another system cannot be made based on purchase price alone. It’s just one reason why not-for-profit board members must […]

Posted in Partnerships, M&A, and Finance